Active Wound Care Market Size, Share and Industry Analysis by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings, Others), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), By End User (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2032

Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Prevalence of Key Disease Indications (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers Etc.) forKey Countries/Region

4.2 Recent Industry Developments  such as Partnerships,Mergers & Acquisitions

4.3 New Product Launches

4.4 Regulatory Framework by Key Countries

4.5 Reimbursement Scenario, Key Countries

4.6 Economic Cost Burden For The Treatment Of Chronic Wounds By Key Countries/ Region

5. Global Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Product Type

5.2.1 Biological Skin Equivalents

5.2.1.1 Allografts

5.2.1.2 Xenografts

5.2.1.3 Cell-based Therapies

5.2.2 Growth Factors

5.2.2.1 Epidermal Growth Factors

5.2.2.2 Platelet-derived Growth Factors

5.2.2.3 Others

5.2.3 Biological Dressings

5.2.3.1 Collagen Dressings

5.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

5.2.4 Others

5.3. Market Analysis, Insights and Forecast – By Indication

5.3.1 Diabetic Foot Ulcers

5.3.2 Pressure Ulcers

5.3.3 Lower Limb Ulcers

5.3.4 Others

5.4. Market Analysis, Insights and Forecast – By End User

5.4.1 Hospitals

5.4.2 Clinics

5.4.3 Home Care Settings

5.4.4 Others

5.5. Market Analysis, Insights and Forecast – By Region

5.5.1 North America

5.5.2 Europe

5.5.3 Asia Pacific

5.5.4 Latin America

5.5.5 Middle East & Africa

6. North America Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

6.1. Key Findings / Summary

6.2. Market Analysis, Insights and Forecast – By Product Type

6.2.1 Biological Skin Equivalents

6.2.1.1 Allografts

6.2.1.2 Xenografts

6.2.1.3 Cell-based Therapies

6.2.2 Growth Factors

6.2.2.1 Epidermal Growth Factors

6.2.2.2 Platelet-derived Growth Factors

6.2.2.3 Others

6.2.3 Biological Dressings

6.2.3.1 Collagen Dressings

6.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

6.2.4 Others

6.3. Market Analysis, Insights and Forecast – By Indication

6.3.1 Diabetic Foot Ulcers

6.3.2 Pressure Ulcers

6.3.3 Lower Limb Ulcers

6.3.4 Others

6.4. Market Analysis, Insights and Forecast– By End User

6.4.1 Hospitals

6.4.2 Clinics

6.4.3 HomeCare Settings

6.4.4 Others

6.5. Market Analysis, Insights and Forecast – By Country

6.5.1 U.S.

6.5.2 Canada

7. Europe Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

7.1. Key Findings / Summary

7.2. Market Analysis, Insights and Forecast– By Product Type

7.2.1 Biological Skin Equivalents

7.2.1.1 Allografts

7.2.1.2 Xenografts

7.2.1.3 Cell-based Therapies

7.2.2 Growth Factors

7.2.2.1 Epidermal Growth Factors

7.2.2.2 Platelet-derived Growth Factors

7.2.2.3 Others

7.2.3 Biological Dressings

7.2.3.1 Collagen Dressings

7.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

7.2.4 Others

7.3. Market Analysis, Insights and Forecast – By Indication

7.3.1 Diabetic Foot Ulcers

7.3.2 Pressure Ulcers

7.3.3 Lower Limb Ulcers

7.3.4 Others

7.4. Market Analysis, Insights and Forecast – By End User

7.4.1 Hospitals

7.4.2 Clinics

7.4.3 Home Care Settings

7.4.4 Others

7.5. Market Analysis, Insights and Forecast – By Country/ Sub-region

7.5.1 Germany

7.5.2 U.K.

7.5.3 France

7.5.4 Italy

7.5.5 Spain

7.5.6 Scandinavia

7.5.7 Rest of Europe

8. Asia Pacific Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

8.1. Key Findings / Summary

8.2. Market Analysis, Insights and Forecast – By Product Type

8.2.1 Biological Skin Equivalents

8.2.1.1 Allografts

8.2.1.2 Xenografts

8.2.1.3 Cell-based Therapies

8.2.2 Growth Factors

8.2.2.1 Epidermal Growth Factors

8.2.2.2 Platelet-derived Growth Factors

8.2.2.3 Others

8.2.3 Biological Dressings

8.2.3.1 Collagen Dressings

8.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

8.2.4 Others

8.3. Market Analysis, Insights and Forecast – By Indication

8.3.1 Diabetic Foot Ulcers

8.3.2 Pressure Ulcers

8.3.3 Lower Limb Ulcers

8.3.4 Others

8.4. Market Analysis, Insights and Forecast – By End User

8.4.1 Hospitals

8.4.2 Clinics

8.4.3 Home Care Settings

8.4.4 Others

8.5. Market Analysis, Insights and Forecast – By Country/ Sub-region

8.5.1 China

8.5.2 India

8.5.3 Japan

8.5.4 Australia

8.5.5 South East Asia

8.5.6 Rest of Asia Pacific

9. Latin America Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

9.1. Key Findings / Summary

9.2. Market Analysis, Insights and Forecast – By Product Type

9.2.1 Biological Skin Equivalents

9.2.1.1 Allografts

9.2.1.2 Xenografts

9.2.1.3 Cell-based Therapies

9.2.2 Growth Factors

9.2.2.1 Epidermal Growth Factors

9.2.2.2 Platelet-derived Growth Factors

9.2.2.3 Others

9.2.3 Biological Dressings

9.2.3.1 Collagen Dressings

9.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

9.2.4 Others

9.3. Market Analysis, Insights and Forecast – By Indication

9.3.1 Diabetic Foot Ulcers

9.3.2 Pressure Ulcers

9.3.3 Lower Limb Ulcers

9.3.4 Others

9.4. Market Analysis, Insights and Forecast – By End User

9.4.1 Hospitals

9.4.2 Clinics

9.4.3 Home Care Settings

9.4.4 Others

9.5. Market Analysis, Insights and Forecast– By Country/ Sub-region

9.5.1 Brazil

9.5.2 Mexico

9.5.3 Rest of Latin America

10. Middle East &Africa Active Wound Care Market Analysis, Insights and Forecast, 2014-2025

10.1. Key Findings / Summary

10.2. Market Analysis, Insights and Forecast– By Product Type

10.2.1 Biological Skin Equivalents

10.2.1.1 Allografts

10.2.1.2 Xenografts

10.2.1.3 Cell-based Therapies

10.2.2 Growth Factors

10.2.2.1 Epidermal Growth Factors

10.2.2.2 Platelet-derived Growth Factors

10.2.2.3 Others

10.2.3 Biological Dressings

10.2.3.1 Collagen Dressings

10.2.3.2 Active Dressings (Honey Impregnated Dressings, etc.)

10.2.4 Others

10.3. Market Analysis, Insights and Forecast – By Indication

10.3.1 Diabetic Foot Ulcers

10.3.2 Pressure Ulcers

10.3.3 Lower Limb Ulcers

10.3.4 Others

10.4. Market Analysis, Insights and Forecast – By End User

10.4.1 Hospitals

10.4.2 Clinics

10.4.3 Home Care Settings

10.4.4 Others

10.5. Market Analysis, Insights and Forecast – By Country/ Sub-region

10.5.1 South Africa

10.5.2 GCC

10.5.3 Rest of Middle East & Africa

11. Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2017)

11.3. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies,financials (based on availability))

11.3.1 MiMedx

11.3.2 TissueRegenix

11.3.3 Smith& Nephew

11.3.4 Organogenesis Inc.

11.3.5 AcellInc.

11.3.6 Integra Life Sciences

11.3.7 Solsys Medical

11.3.8 Osiris Therapeutics, Inc.

12. Strategic Recommendations